Tirzepatide-induced ketoacidosis with hyperglycemia in a patient without diabetes
Abstract Tirzepatide,a dual GLP-1 and GIP receptor agonist, is increasingly used for weight management in both patients with diabetes and patients without diabetes. While gastrointestinal side effects such as nausea are common, severe metabolic complications like ketoacidosis are rare and often over...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Sociedade Brasileira de Endocrinologia e Metabologia
2026-05-01
|
| Edice: | Archives of Endocrinology and Metabolism |
| Témata: | |
| On-line přístup: | http://www.scielo.br/pdf/aem/v70n3/2359-4292-aem-70-03-e260028.pdf |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|